Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

FDA approves omalizumab for food allergy reactions based on NIH research

FDA approves omalizumab for food allergy reactions based on NIH research

Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity

Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity

Combination therapy offers breakthrough in NSCLC treatment

Combination therapy offers breakthrough in NSCLC treatment

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Rice scientists identify promising new immunological pathway to treat breast cancer bone metastases

Rice scientists identify promising new immunological pathway to treat breast cancer bone metastases

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Annexin-A1 targeted therapy beats several cancers

Annexin-A1 targeted therapy beats several cancers

New blood test technique raises hopes for more sensitive and earlier cancer diagnosis

New blood test technique raises hopes for more sensitive and earlier cancer diagnosis

CGRP antagonists and dietary changes show promise for migraine treatment

CGRP antagonists and dietary changes show promise for migraine treatment

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

New study finds maternal vaccine and monoclonal antibody effective against RSV in infants

New Omicron subvariants test vaccine limits, reveal unique infection challenges

New Omicron subvariants test vaccine limits, reveal unique infection challenges

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

Antibody treatment shields transplant patients against COVID-19

Antibody treatment shields transplant patients against COVID-19

Small molecule applications of process Raman spectroscopy

Small molecule applications of process Raman spectroscopy

Promising candidate medication for preventing and reversing fentanyl-induced overdose

Promising candidate medication for preventing and reversing fentanyl-induced overdose

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

New mechanism revealed for how group A Streptococcus infection reduces type 1 diabetes risk

Survey: Over a third of Americans worry about the "tripledemic" of respiratory illnesses

Survey: Over a third of Americans worry about the "tripledemic" of respiratory illnesses